How long is the validity period of Axitinib (Inlida) and the effects of improper storage?

Axitinib is an oral small molecule tyrosine kinase inhibitor mainly used to treat advanced renal cell carcinoma. On drug packaging, manufacturers usually mark the expiry date (usually 2 to 3 years). This time refers to the period during which the drug can maintain stability and efficacy under sealed and suitable conditions. During the validity period, the active ingredient of the drug can maintain sufficient concentration to ensure therapeutic efficacy and safety.

Drugs should be stored according to the instructions during the validity period. Axitinib usually needs to be stored at room temperature, in a dry environment, away from light, and away from moisture, high temperature or direct sunlight. After opening, medicines must remain in their original packaging and avoid contact with air and moisture. Proper storage conditions can not only extend the service life of drugs, but also ensure stable efficacy of the drugs when taken and reduce the probability of potential adverse reactions.

Improper storage of medicines may lead to drug degradation or reduced activity, thereby reducing efficacy. For example, high temperature or humid environments may cause axitinib tablets to become hygroscopic, discolored or ineffective, while long-term exposure to light may accelerate the decomposition of the drug ingredients. In addition, incorrect storage may increase the risk of impurity formation, leading to a decrease in drug safety, and may increase gastrointestinal discomfort or other adverse reactions after taking it.

Therefore, patients should strictly follow the expiry date and storage requirements on the instructions while using axitinib. Do not use medicines that have exceeded their expiration date or have been stored under improper conditions to avoid affecting the therapeutic effect. At the same time, the appearance of the medicine should be checked regularly. If the tablets are found to be damaged, discolored or have an odor, they should consult a pharmacist or doctor in time to ensure safe medication use. By correctly storing and paying attention to the expiration date, the efficacy and patient safety of axitinib in the treatment of renal cell carcinoma can be ensured to the greatest extent.

Reference materials:https://www.drugs.com/